Development and validation of stability indicating RP-HPLC method for nebivolol by using the DOE approach
Background: Nebivolol (NBV), classified as a third-generation β1-adrenergic receptor antagonist, is commonly prescribed for managing hypertension. Accurate and prompt quantification of NBV in bulk materials and pharmaceutical formulations is crucial for quality assurance. This research focuses on de...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Creative Pharma Assent
2025-06-01
|
| Rangatū: | Journal of Applied Pharmaceutical Research |
| Ngā marau: | |
| Urunga tuihono: | https://japtronline.com/index.php/joapr/article/view/1062 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|